SiliCycle receives its cannabis processing license from Health Canada
August 6th, 2020
QUEBEC CITY, Aug. 5, 2020 /CNW Telbec/ – Senior management of SiliCycle is pleased to have taken a new step towards the commercialization of purified extracts of various cannabinoids with the obtention of its cannabis processing license from Health Canada. The Quebec-based company can thus move forward to transform the biomass of hemp and cannabis into pure, high-quality extracts.
The authorization provided by Health Canada allows SiliCycle to start production -at its new plant – located in Quebec City, which was completed in early 2020. More than 22 million dollars were invested in construction and equipment acquisition costs related to carrying out the extraction, purification and packaging processes used by the company and its affiliate PurCann Pharma, which is dedicated to this field of expertise.
“There is certainly a craze for the production of cannabinoids, but the interest lies particularly in the ability to offer these substances in their pure form – This is precisely where we set ourselves apart with processes that allow us to produce the desired quantities and proportions in a stable and reproducible manner despite the variations -in the biomass. This is how we will be able to provide customers with -reliable products, an essential condition for commercial success,” said SiliCycle President Hugo St-Laurent.
The new plant will process up to 100,000 kg of biomass per year, thus providing SiliCycle with the tools to produce thousands of kilograms of extracts – with varying degrees of purity according to the needs of its customers. The new plant is also equipped with units for the preparation of finished products including tinctures, sprays and so on, to meet customer needs.-
“We are applying all the expertise acquired in the pharmaceutical field to ensure product quality and reproducibility according to very high standards. Our scientific approach is therefore rigorous and proven, combined with the quality of our new facilities and the presence of high-caliber researchers within our team, thus we are well positioned to successfully market our products”, said Pierre Plante, Vice President – Operations for PurCann Pharma.
About SiliCycle Inc.
Founded in 1995, SiliCycle Inc. is a worldwide leader in the development, the manufacturing and the commercialization of high value silica-based and specialty products for chromatography, analytical and organic chemistry. Our business extends to more than fifty countries and our customer portfolio includes companies in the pharmaceutical and biopharmaceutical industries, contract research and manufacturing organizations as well as university laboratories, hospital research centers, agriculture and food, environmental, petrochemicals, and industrial process companies. Our offer includes among others services:
- Aqueous or organic extraction of various molecules from various biomasses
- Customized purification of the scale from laboratory to industrial
- Development of analytical methods to achieve the desired levels of purity
- Synthesis of molecules of interest
- Production of active ingredients such as omega-3s, polyphenols and CBD / THC molecules
About PurCann Pharma
PurCann Pharma is specialized in the manufacturing and commercialization of cannabinoid-rich extracts from hemp and cannabis grown in Canada. A significant portion of these biomasses is certified Organic. The purified and standardized extracts rich in CBD and / or THC are sold in bulk or as finished products, such as tinctures, sprays, softgels. PurCann Pharma also offers R&D, extraction, purification and packaging services.
To learn more about SiliCycle’s activities, follow us on social media:
For further information: Hugo St-Laurent, President, 418 874.0054, [email protected]; Pierre Plante, Vice President – Operations, PurCann Pharma, 514 804-4416, [email protected]; Pierre Drapeau, Head of Public Affairs, 418 456.6385, [email protected]
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.